Yüklüyor......
Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission
BACKGROUND/AIM: Acromegaly is associated with increased morbidity and mortality, mostly due to cardiovascular complications. Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels are associated with coagulation/fibrinolysis and inflammation. Plasma TAFI may play a role in arterial...
Kaydedildi:
| Yayımlandı: | Turk J Med Sci |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Scientific and Technological Research Council of Turkey
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7018305/ https://ncbi.nlm.nih.gov/pubmed/31549496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-1812-231 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|